Anti-therapeutic antibodies and their clinical impact in patients treated with the TNF antagonist adalimumab.

Home > References > 2017 > Anti-therapeutic antibodies and their clinical impact in patients treated with the TNF antagonist adalimumab.

Contact an Account Manager

Cludts I, Spinelli FR, Morello F, Hockley J, Valesini G, Wadhwa M.

By Analytes

By Applications

Customer Service/Orders
1-240-314-2795

5:00 a.m. to 8:00 p.m.
US Eastern Time

Email

Scientific/Technical Support
1-240-314-2798

8:30 a.m. to 5:30 p.m.
US Eastern Time

Email

Instrument Support
1-301-947-2057

8:30 a.m. - 5:30 p.m.
US Eastern Time

Email

Company Headquarters
1-240-314-2600
1601 Research Blvd.
Rockville, Maryland 20850-3173
USA

Please Sign In